BioSpace News Archive

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies, provided an update on its ophthalmology programs following feedback from the European Medicines Agency related to sepofarsen and will now focus exclusively on its Axiomer® RNA-editing technology platform.

Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™) therapeutics as a new class of medicines, today reported financial results for the second quarter ended June 30, 2022 and highlighted recent business updates.

ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), today announced the initiation of a Phase 2 investigator-sponsored study of evorpacept, a next generation CD47 blocker, in combination with ERBITUX® (cetuximab) and KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with refractory microsatellite stable metastatic colorectal cancer (“mCRC”) who have progressed on at least two lines of systemic therapy.

Shattuck Labs, Inc. today reported financial results for the quarter ended June 30, 2022 and provided recent business highlights.

BioLineRx Ltd. announced today it will release its unaudited financial results for the quarter ended June 30, 2022 on Tuesday, August 16, 2022, before the US markets open.

Theseus Pharmaceuticals, Inc. today announced business and pipeline highlights and reported financial results for the second quarter ended June 30, 2022.

Ginkgo Bioworks and the Rwanda Development Board today announced that they have entered into a Memorandum of Understanding (“MOU”) with the intent of developing and implementing new biosecurity capabilities in Rwanda.

Virios Therapeutics, Inc. today announced financial results for the second quarter ended June 30, 2022.

Quipt Home Medical Corp. a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced that members of its management team will host a webcasted presentation and participate in 1x1 meetings with institutional investors at the upcoming Sidoti Virtual Investor Conference on August 17th – 18th.

IMV Inc. today announced its financial and operational results and provided an update for the second quarter ended June 30, 2022.